HCPCS Level II code C7500 represents surgical debridement of bone and associated soft tissues (epidermis, dermis, subcutaneous tissue, muscle and/or fascia) for the first 20 square centimeters or less performed with manual preparation and insertion of deep drug-delivery device(s). This code captures combined operative management when debridement and implantation of a subfacial or similarly deep drug-delivery system occur during the same procedure. Nationally, accurate use of this code affects hospital and ambulatory surgery center billing for complex wound and device-based therapies and informs utilization reporting for deep implantable drug-delivery interventions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical scope and service context, an outline of common modifiers that may accompany the procedure, typical sites of service, and guidance on what benchmark and policy elements are considered when evaluating coverage and claims handling for deep debridement with device insertion. The publication also summarizes clinical considerations relevant to procedure reporting and highlights areas where payer policy language and claims adjudication practices commonly intersect with coding choices.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.